Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women

Objective: There are diverse findings concerning the use of platelet-rich plasma (PRP) in assisted reproduction treatment (ART) cycles of infertile women with low ovarian reserve, ovarian failure or implantation failure due to endometrial problems. A debate continues regarding the benefit of this te...

Full description

Bibliographic Details
Main Authors: Pelin Kutlu, Seda Karabulut, Oya Korkmaz
Format: Article
Language:English
Published: IMR Press 2021-10-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/48/5/10.31083/j.ceog4805165
_version_ 1811247766761897984
author Pelin Kutlu
Seda Karabulut
Oya Korkmaz
author_facet Pelin Kutlu
Seda Karabulut
Oya Korkmaz
author_sort Pelin Kutlu
collection DOAJ
description Objective: There are diverse findings concerning the use of platelet-rich plasma (PRP) in assisted reproduction treatment (ART) cycles of infertile women with low ovarian reserve, ovarian failure or implantation failure due to endometrial problems. A debate continues regarding the benefit of this technique because of the low number of evidence-based studies. Mechanism: Different PRP preparation methods have been described in the literature, aiming to obtain the highest number of platelets following centrifugation steps. Findings in brief: Research on the use of PRP in female infertility aims to improve the deteriorated hormonal profile, gamete production and implantation of the embryo into the endometrium. Conclusions: This paper reviewed literature evaluating the impact of PRP on the outcomes of subsequent ART cycles in infertile women. PRP is a safe and easy-to-apply procedure and can be used as an ’add-on’ therapy in patients with reduced ovarian reserve, ovarian failure or implantation failure prior to the in vitro fertilization (IVF) cycle, although it is still regarded as an empirical treatment method. Further studies should be conducted to enlighten the subject.
first_indexed 2024-04-12T15:15:24Z
format Article
id doaj.art-821471301c2f4215b7228b05e037f211
institution Directory Open Access Journal
issn 0390-6663
language English
last_indexed 2024-04-12T15:15:24Z
publishDate 2021-10-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj.art-821471301c2f4215b7228b05e037f2112022-12-22T03:27:38ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632021-10-014851025103110.31083/j.ceog4805165S0390-6663(21)00005-1Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile womenPelin Kutlu0Seda Karabulut1Oya Korkmaz2Istanbul Medicana Çamlıca Hospital, IVF Center, 34692 İstanbul, TurkeyDepartment of Histology and Embryology, School of Medicine, Istanbul Medipol University, 34815 İstanbul, TurkeyDepartment of Histology and Embryology, School of Medicine, Istanbul Medipol University, 34815 İstanbul, TurkeyObjective: There are diverse findings concerning the use of platelet-rich plasma (PRP) in assisted reproduction treatment (ART) cycles of infertile women with low ovarian reserve, ovarian failure or implantation failure due to endometrial problems. A debate continues regarding the benefit of this technique because of the low number of evidence-based studies. Mechanism: Different PRP preparation methods have been described in the literature, aiming to obtain the highest number of platelets following centrifugation steps. Findings in brief: Research on the use of PRP in female infertility aims to improve the deteriorated hormonal profile, gamete production and implantation of the embryo into the endometrium. Conclusions: This paper reviewed literature evaluating the impact of PRP on the outcomes of subsequent ART cycles in infertile women. PRP is a safe and easy-to-apply procedure and can be used as an ’add-on’ therapy in patients with reduced ovarian reserve, ovarian failure or implantation failure prior to the in vitro fertilization (IVF) cycle, although it is still regarded as an empirical treatment method. Further studies should be conducted to enlighten the subject.https://www.imrpress.com/journal/CEOG/48/5/10.31083/j.ceog4805165infertilityivfplatelet-rich plasma (prp)ovarian failure
spellingShingle Pelin Kutlu
Seda Karabulut
Oya Korkmaz
Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women
Clinical and Experimental Obstetrics & Gynecology
infertility
ivf
platelet-rich plasma (prp)
ovarian failure
title Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women
title_full Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women
title_fullStr Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women
title_full_unstemmed Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women
title_short Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women
title_sort administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women
topic infertility
ivf
platelet-rich plasma (prp)
ovarian failure
url https://www.imrpress.com/journal/CEOG/48/5/10.31083/j.ceog4805165
work_keys_str_mv AT pelinkutlu administrationofautologousplateletrichplasmaandtheimpactonoutcomesofassistedreproductiontreatmentininfertilewomen
AT sedakarabulut administrationofautologousplateletrichplasmaandtheimpactonoutcomesofassistedreproductiontreatmentininfertilewomen
AT oyakorkmaz administrationofautologousplateletrichplasmaandtheimpactonoutcomesofassistedreproductiontreatmentininfertilewomen